BridgeMD
New treatment option for Cerebral Palsy, Spastic
Official title Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.
ClinicalTrials.gov ID: NCT06640894
What this study is testing
- What it's testing
- Rationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12.
- Gross Motor Function Classification System (GMFCS) level I - III.
- Parents and/or children have a treatment question related to participation of the child.
You likely can't join if
- Participants that suffer from a progressive neurological disorder.
- Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period.
- Treatment with botulinum toxin in the twelve weeks prior to participation in the study.
- Treatment with serial casting in the three weeks prior to participation in the study.
- Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study.
- Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study.
See the full eligibility criteria
- Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12.
- Gross Motor Function Classification System (GMFCS) level I - III.
- Parents and/or children have a treatment question related to participation of the child.
- Participants that suffer from a progressive neurological disorder.
- Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period.
- Treatment with botulinum toxin in the twelve weeks prior to participation in the study.
- Treatment with serial casting in the three weeks prior to participation in the study.
- Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study.
- Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study.
- Children that have received MegaPower training in the last 4 months before participation in the study.
- Children for whom walking is not their preferred method of locomotion (yet).
The study team makes the final eligibility decision.
Where it's taking place
- Emmen, Drenthe, Netherlands
- Almere Stad, Flevoland, Netherlands
- Valkenburg, Limburg, Netherlands
- Breda, North Brabant, Netherlands
- Amsterdam, North Holland, Netherlands
- Heemskerk, North Holland, Netherlands
- Hilversum, North Holland, Netherlands
- Enschede, Overijssel, Netherlands
- Beetsterzwaag, Provincie Friesland, Netherlands
- Goes, Zeeland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Emmen, Drenthe, Netherlands; Almere Stad, Flevoland, Netherlands; Valkenburg, Limburg, Netherlands; Breda, North Brabant, Netherlands; Amsterdam, North Holland, Netherlands; Heemskerk, North Holland, Netherlands and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.